Shaheen Shamsavari
Vice President of Sales and Business Development at Xandex
Petaluma, California
Overview
Work Experience
Vice President of Sales and Business Development
2023 - Current
Director - Venture Investments & Business Development
2007 - 2023
Includes Business Development roles in Xandex Semiconductor, Xandex Investments LLC, and Xandex - Solar Division.
Xandex is a semiconductor company providing solar energy and semiconductor services.
Memeber/Investor
2012
Berkeley Angel Network is a venture capital and private equity firm that specializes in the fields of finance and investment management.
Member/Investor
2007
Active Investor and 2013 Co-Chair for the Device Screening Committee.
Board Observer
2014 - 2020
Advisor
2013 - 2020
• Business Model Strategy (Financial Modeling, Product Realization, Go-to-Market Strategy) • Seed, Bridge to Series A, Series A Fundraising Strategy • Liaison to relevant angel/VC investor networks for Seed and Series A fundraising
Founding Member/Investor
2010 - 2015
Member/Investor
2007 - 2014
Keiretsu Forum is a California-based angel group that offers early, seed, and later stage venture, and debt financing investments.
Member/Investor
2011 - 2012
Golden Seeds is a network of angel investors dedicated to investing in early stage companies founded and/or led by women. Golden Seeds has more than 170 accredited investors, with locations in New York, Philadelphia, Boston and San Francisco. Members invest directly or through a managed fund in sectors that include consumer products, technology, software and life sciences. Members also participate in screening and supporting these new businesses with their expertise and experience. Golden Seeds is dedicated to empowering women financially, based on a commitment that diversity in business ownership and management improves corporate performance and creates a stronger economy.
Golden Seeds is a seed-stage investment firm that focuses on women entrepreneurs.
Research Associate
2006 - 2007
Formulations and Process Development - Preclinical development of HIV and Hepatitis C therapeutics.
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Raised $4,413,500,000.00 from Abingworth.
Education
BS
2001 - 2006